Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beer

Showing results (831-840 of 888) with videos related to

Pageof 89
Sort By:
The New England Journal of Medicine|June 23, 2021
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate CancerOliver Sartor, Johann de Bono, Kim N Chi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate CancerTomasz M Beer, Eugene D Kwon, Charles G Drake, et al.
The Journal of Urology|April 18, 2007
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot studyAdam S Kibel, Eli Rosenbaum, Michael W Kattan, et al.
Urologic Oncology|July 7, 2020
Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancerDaniel H Kwon, Li Zhang, David A Quigley, et al.
Cancer Discovery|April 29, 2017
Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of <i>BRCA2</i> Reversion Mutations Associated with Resistance to PARP InhibitorsDavid Quigley, Joshi J Alumkal, Alexander W Wyatt, et al.
Journal of Comparative Pathology|February 19, 2014
Polar bear encephalitis: establishment of a comprehensive next-generation pathogen analysis pipeline for captive and free-living wildlifeC A Szentiks, K Tsangaras, B Abendroth, et al.
JAMA Oncology|February 10, 2022
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical TrialNicholas J Vogelzang, Tomasz M Beer, Winald Gerritsen, et al.
Clinical and Translational Science|August 29, 2024
Lexicon for blood-based early detection and screening: BLOODPAC consensus documentChristina A Clarke, Breeana L Mitchell, Girish Putcha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2025
Navigating Complexity: Perspectives on Risk Assessment in the Era of New Blood-Based Tests for Early Cancer DetectionChristina A Clarke, Breeana L Mitchell, Emma Alme, et al.
Scientific Reports|July 13, 2022
Transatlantic spread of highly pathogenic avian influenza H5N1 by wild birds from Europe to North America in 2021V Caliendo, N S Lewis, A Pohlmann, et al.
Pageof 89

Showing results (831-840 of 888) with videos related to

Sort By:
Pageof 89
The New England Journal of Medicine|June 23, 2021
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate CancerOliver Sartor, Johann de Bono, Kim N Chi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate CancerTomasz M Beer, Eugene D Kwon, Charles G Drake, et al.
The Journal of Urology|April 18, 2007
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot studyAdam S Kibel, Eli Rosenbaum, Michael W Kattan, et al.
Urologic Oncology|July 7, 2020
Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancerDaniel H Kwon, Li Zhang, David A Quigley, et al.
Cancer Discovery|April 29, 2017
Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of <i>BRCA2</i> Reversion Mutations Associated with Resistance to PARP InhibitorsDavid Quigley, Joshi J Alumkal, Alexander W Wyatt, et al.
Journal of Comparative Pathology|February 19, 2014
Polar bear encephalitis: establishment of a comprehensive next-generation pathogen analysis pipeline for captive and free-living wildlifeC A Szentiks, K Tsangaras, B Abendroth, et al.
JAMA Oncology|February 10, 2022
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical TrialNicholas J Vogelzang, Tomasz M Beer, Winald Gerritsen, et al.
Clinical and Translational Science|August 29, 2024
Lexicon for blood-based early detection and screening: BLOODPAC consensus documentChristina A Clarke, Breeana L Mitchell, Girish Putcha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2025
Navigating Complexity: Perspectives on Risk Assessment in the Era of New Blood-Based Tests for Early Cancer DetectionChristina A Clarke, Breeana L Mitchell, Emma Alme, et al.
Scientific Reports|July 13, 2022
Transatlantic spread of highly pathogenic avian influenza H5N1 by wild birds from Europe to North America in 2021V Caliendo, N S Lewis, A Pohlmann, et al.
Pageof 89